BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is being made by the company to raise funds for various purposes including purchasing gold bullion.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Proposed Public Offering
BioSig Technologies intends to offer shares of common stock to raise funds for purchasing gold bullion and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Registration Statement
The offering is being made pursuant to a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the SEC on December 17, 2024.
- The completion of the offering remains subject to market conditions with no assurance regarding its timing, size, or terms.
- Interested parties should read the preliminary prospectus supplement and accompanying base prospectus for more information about the offering.
BioSig Technologies Inc. is taking strategic steps to raise funds through a public offering, demonstrating its commitment to its investment policy and corporate objectives.